Table 3.
Remnant-C | Unadjusted | Model 1 | Model 2 | Model 3 | ||||
---|---|---|---|---|---|---|---|---|
HR (95% CI) | P value | HR (95% CI) | P value | HR (95% CI) | P value | HR (95% CI) | P value | |
MACEs | ||||||||
logSD | 1.52 (1.31–1.76) | <0.001 | 1.45 (1.22–1.73) | <0.001 | 1.39 (1.16–1.65) | <0.001 | 1.41 (1.18–1.69) | <0.001 |
logARV | 1.57 (1.35–1.82) | <0.001 | 1.49 (1.25–1.77) | <0.001 | 1.43 (1.20–1.71) | <0.001 | 1.45 (1.22–1.73) | <0.001 |
logCV | 1.31 (1.02–1.69) | 0.035 | 1.11 (0.84–1.49) | 0.461 | 1.04 (0.78–1.39) | 0.770 | 1.06 (0.79–1.41) | 0.700 |
CVD death | ||||||||
logSD | 1.31 (1.02–1.69) | 0.037 | 1.39 (1.03–1.87) | 0.029 | 1.28 (0.94–1.73) | 0.111 | 1.27 (0.94–1.72) | 0.120 |
logARV | 1.42 (1.10–1.83) | 0.007 | 1.57 (1.17–2.12) | 0.003 | 1.47 (1.08–1.99) | 0.013 | 1.46 (1.08–1.97) | 0.014 |
logCV | 1.03 (0.67–1.57) | 0.901 | 1.03 (0.63–1.68) | 0.910 | 0.93 (0.57–1.53) | 0.786 | 0.92 (0.56–1.51) | 0.743 |
Nonfatal MI | ||||||||
logSD | 2.07 (1.69–2.52) | <0.001 | 1.91 (1.51–2.41) | <0.001 | 1.86 (1.46–2.36) | <0.001 | 1.92 (1.51–2.43) | <0.001 |
logARV | 2.04 (1.67–2.50) | <0.001 | 1.90 (1.50–2.40) | <0.001 | 1.86 (1.47–2.36) | <0.001 | 1.90 (1.50–2.40) | <0.001 |
logCV | 2.09 (1.48–2.95) | 0.000 | 1.63 (1.10–2.43) | 0.016 | 1.67 (1.05–2.33) | 0.027 | 1.62 (1.09–2.42) | 0.017 |
Nonfatal stroke | ||||||||
logSD | 1.22 (0.92–1.62) | 0.176 | 1.28 (0.92–1.78) | 0.136 | 1.23 (0.88–1.72) | 0.218 | 1.26 (0.90–1.76) | 0.175 |
logARV | 1.25 (0.94–1.67) | 0.126 | 1.28 (0.92–1.78) | 0.142 | 1.24 (0.89–1.73) | 0.207 | 1.26 (0.90–1.76) | 0.171 |
logCV | 0.92 (0.57–1.48) | 0.728 | 0.89 (0.52–1.52) | 0.665 | 0.83 (0.48–1.43) | 0.502 | 0.84 (0.49–1.45) | 0.535 |
Model 1: Adjusted for sex, age, education, years of hypertension diagnosis, depression, smoking habit, alcohol consumption, systolic blood pressure, diastolic blood pressure, heart rate, BMI, and CVD history. Model 2: Adjusted for model 1 covariables plus levels of plasma glucose, eGFR, HbA1c, and LDL-C. Model 3: Adjusted for model 2 covariables plus treatment with biguanide, statins, and insulin.